MINI FUTURE OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000JA21K10

Market Closed - Börse Stuttgart 13:37:39 17/05/2024 BST
3.17 EUR +1.60% Intraday chart for MINI FUTURE OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-5.93%
1 month-16.14%
Date Price Change
17/05/24 3.17 +1.60%
16/05/24 3.12 -1.58%
15/05/24 3.17 -1.86%
14/05/24 3.23 -0.92%
13/05/24 3.26 0.00%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 01:37 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
Issuer J.P. Morgan
WKN JA21K1
ISINDE000JA21K10
Date issued 28/03/2022
Strike 72.13
Maturity Unlimited
Parity 10 : 1
Emission price 1.9
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.85
Lowest since issue 1.42
Spread 0.04
Spread %1.24%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
40.46 EUR
Average target price
39.48 EUR
Spread / Average Target
-2.42%
Consensus